Last update :
19/11/2024
Anticancer drug   Pertuzumab  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Perjeta Argentina, Australia, Belgium, Brazil, Canada, Chile, Ecuador, Finland, France, Germany, Great Britain, Hungary, Iceland, Ireland, Italy, Japan, Luxembourg, Mexico, Norway, Peru, Romania, Slovenia, Spain, Sweden, Switzerland, Tunisia, Turkey, United States of America
References   injection   References : Pertuzumab  
Type Publication
2296 Manufacturer Témocilline (Negaban®) - Résumé des caractéristiques du produit
Eumedica 2017
3366 Journal Kwong Glover Z.W, Gennaro L, Yadav S, Demeule B, Wong P.Y, Sreedhara A.
Compatibility and stability of pertuzumab and trastuzumab admixtures in i.v. infusion bags for coadministration.
J Pharm Sci 2012 ; DOI 10.1002 / jps.23403
4686 Manufacturer Pertuzumab (Perjeta®) - Summary of Product Characteristics.
Roche Products Ltd. 2022

  Mentions Légales